## Filing Overview

**Filing Date**: August 11, 2022  
**Type of Filing**: [[Filing Definitions#Prospectus Supplement|Prospectus Supplement]]  
**Linked Document**s:  
-  [[8-11-22 10-Q - Quarterly Report]]
-  [[5-04-22 EFFECT - 333-259797]]
-  [[5-04-22 EFFECT - 333-257440]]

---

## Notes

- This supplement updates the **Prospectus dated May 4, 2022**, forming part of Rocket Lab’s Registration Statements **333-259797** and **333-257440**.  
- It incorporates information from Rocket Lab’s **Form 10-Q for Q2 2022**, filed on August 11, 2022, covering the quarter ending June 30, 2022.  

### Highlights:
- **Financial Updates**:
  - Revenue: **$55.5 million** for Q2 2022.  
  - Net Loss: **$(37.2 million)** for Q2 2022.  
  - Cash and cash equivalents: **$542.1 million** as of June 30, 2022.  

- **Operational Updates**:
  - Continued progress with Electron launches.  
  - Updates on the Neutron development program.  

- **Common Stock**:
  - Nasdaq symbol: **RKLB**.  
  - Last reported sale price: **$5.79** as of August 10, 2022.  

This supplement ensures the prospectus remains aligned with the latest financial and operational disclosures, providing investors with current material information.

---
![[4d4ec3fb-d78c-4865-b8c0-1cb720e6b159.pdf]]

#SECFiling #424B3